Peripheral blood stem cell transplantation followed by recombinant alpha interferon for chronic myelogenous leukemia in chronic phase: preliminary results.
Reiffers
J
J
French Society for Bone Marrow Transplantation, Hôpital Haut-Levêque, Pessac.
Cahn
J Y
JY
Montastruc
M
M
Caillot
D
D
Souillet
G
G
Leblond
V
V
Troncy
J
J
Faberes
C
C
D000293:Adolescent; D000328:Adult; D001804:Blood Transfusion, Autologous / Q000009:adverse effects; D002648:Child; D003131:Combined Modality Therapy; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007370:Interferon Type I / Q000627:therapeutic use*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000401:mortality / Q000628:therapy*; D008875:Middle Aged; D011994:Recombinant Proteins; D015996:Survival Rate
D007370:Interferon Type I; D011994:Recombinant Proteins